SE0950633L - Metod och komposition för behandling av allergiska sjukdomar - Google Patents

Metod och komposition för behandling av allergiska sjukdomar

Info

Publication number
SE0950633L
SE0950633L SE0950633A SE0950633A SE0950633L SE 0950633 L SE0950633 L SE 0950633L SE 0950633 A SE0950633 A SE 0950633A SE 0950633 A SE0950633 A SE 0950633A SE 0950633 L SE0950633 L SE 0950633L
Authority
SE
Sweden
Prior art keywords
treatment
composition
allergic diseases
allergic
diseases
Prior art date
Application number
SE0950633A
Other languages
English (en)
Inventor
Bor-Luen Chiang
Chung-Sheng Huang
Original Assignee
Wholesome Biopharm Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wholesome Biopharm Pty Ltd filed Critical Wholesome Biopharm Pty Ltd
Publication of SE0950633L publication Critical patent/SE0950633L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0950633A 2006-03-14 2006-03-14 Metod och komposition för behandling av allergiska sjukdomar SE0950633L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/AU2006/000335 WO2007104070A1 (en) 2006-03-14 2006-03-14 Method and composition for treating allergic diseases

Publications (1)

Publication Number Publication Date
SE0950633L true SE0950633L (sv) 2009-09-03

Family

ID=38508942

Family Applications (2)

Application Number Title Priority Date Filing Date
SE0950633A SE0950633L (sv) 2006-03-14 2006-03-14 Metod och komposition för behandling av allergiska sjukdomar
SE0802191A SE534514C2 (sv) 2006-03-14 2006-03-14 Komposition för behandling av allergiska sjukdomar

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE0802191A SE534514C2 (sv) 2006-03-14 2006-03-14 Komposition för behandling av allergiska sjukdomar

Country Status (8)

Country Link
US (1) US8258104B2 (sv)
EP (1) EP1993564A4 (sv)
JP (1) JP2009529543A (sv)
CN (1) CN101410122A (sv)
AU (1) AU2006339963B2 (sv)
SE (2) SE0950633L (sv)
TW (1) TWI333857B (sv)
WO (1) WO2007104070A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011150441A1 (en) * 2010-06-03 2011-12-08 Wholesome Biopharm Pty Ltd Medical aerosol formulation comprising ribavirin
CA2836511C (en) 2011-06-02 2021-10-19 SOCPRA Sciences Sante et Humaines S.E.C. Matriptase inhibitors and uses thereof against orthomyxoviridae infections
US20160051494A1 (en) * 2014-08-21 2016-02-25 Mylan, Inc. Multi-dose medication kit for treating anaphylaxis
CN108096575B (zh) * 2017-12-25 2021-04-27 成都迈科康生物科技有限公司 一种用于脱敏疫苗的佐剂及一种新型脱敏疫苗

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0262125B1 (en) * 1986-03-27 1996-03-27 Gensia, Inc. AICA riboside for the prophylactic treatment of diseases with restricted blood flow.
DE3815480A1 (de) * 1988-05-06 1989-11-16 Boehringer Ingelheim Kg Synergistische kombinationen und ihre verwendung als therapeutika
CA2109528A1 (en) * 1991-05-01 1992-11-02 Gregory A. Prince A method for treating infectious respiratory diseases
US5240694A (en) * 1991-09-23 1993-08-31 University Of Virginia Combined antiviral and antimediator treatment of common colds
JPH08508007A (ja) * 1991-11-19 1996-08-27 センター フォー イノベイティブ テクノロジー ウィルス抑止性抗両受体によるかぜの複合治療法
US5767097A (en) * 1996-01-23 1998-06-16 Icn Pharmaceuticals, Inc. Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
EP1240899A3 (en) * 1996-01-23 2004-05-19 Ribapharm, Inc. Modulation of Th1/Th2 Cytokine expression by Ribavirin and Ribavirin analogs in actived T-Lymphocytes for treating HCV infections
PL336579A1 (en) * 1997-01-17 2000-07-03 Icn Pharmaceuticals Treatment of diseases associated with cytokinins
CN1222351A (zh) * 1998-12-11 1999-07-14 陈振钰 复方滴鼻液
JP2002535371A (ja) * 1999-01-29 2002-10-22 アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド リバビリンによる免疫応答の調節
WO2001082965A1 (en) * 2000-05-03 2001-11-08 Medimmune, Inc. Combination therapy of respiratory diseases using antibodies
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
US7291331B1 (en) * 2002-09-11 2007-11-06 La Jolla Institute For Allergy And Immunology Methods of treating OX40 medicated recall immune responses
AU2002952559A0 (en) * 2002-11-08 2002-11-21 Fujisawa Pharmaceutical Co., Ltd. New use
CN1698644A (zh) 2004-05-17 2005-11-23 北京扬新科技有限公司 利巴韦林口腔崩解片及制备方法

Also Published As

Publication number Publication date
TW200738247A (en) 2007-10-16
SE0802191L (sv) 2008-10-14
AU2006339963A1 (en) 2007-09-20
WO2007104070A1 (en) 2007-09-20
CN101410122A (zh) 2009-04-15
EP1993564A4 (en) 2010-05-26
JP2009529543A (ja) 2009-08-20
EP1993564A1 (en) 2008-11-26
TWI333857B (en) 2010-12-01
SE534514C2 (sv) 2011-09-20
AU2006339963B2 (en) 2010-02-25
US8258104B2 (en) 2012-09-04
US20090054360A1 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
CY2021009I1 (el) Αντισωματα αντι-ρ-σελεκτινης και μεθοδοι χρησης αυτων στην αντιμετωπιση φλεγμονωδων νοσων
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
SMP200800042B (it) Composizioni e metodi di impiego per anticorpi di dickkopf-1
DE602007004699D1 (de) Aryl(thio)ether-Aryl-Polysiloxan-Zusammensetzung sowie Herstellungs- und Verwendungsverfahren dafür
FI20080492A (sv) Förbättrad ätbar sammansättning och metod för tillverkning därav
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
DE602007004092D1 (de) C-met-proteinkinasehemmer zur behandlung proliferativer erkrankungen
IL193473A0 (en) Amide derivatives and their application for the treatment of g protein related diseases
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
DE602006018583D1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
HK1134679A1 (zh) 用於治療感染的組合物和方法
ATE495179T1 (de) Tetrahydropyridothienpyrimidin-verbindungen und verwendung zur behandlung proliferativer erkrankungen
FI20065431A0 (sv) Modifierad beta-laktamas och förfarande för dess framställning
BRPI0718129A2 (pt) Método para o tratamento de partículas pigmentares e composições farmacêuticas para o cuidado pessoal compreendendo as referidas partículas pigmentare
FI20095600A (sv) Komposition för behandling av hudsjukdomar
ATE525355T1 (de) 1-ä(4-äbenzoyl(methyl)aminoü-3- (phenyl)butylüazetidinderivate zur behandlung von gastrointestinalen erkrankungen 1
DE602007009877D1 (de) Isosorbid-mononitrat-derivate zur behandlung von darmerkrankungen
HK1139334A1 (en) Method of treating demyelination diseases
SE0950633L (sv) Metod och komposition för behandling av allergiska sjukdomar
ATE448228T1 (de) Pyrrolopyrimidinderivate zur behandlung proliferativer krankheiten
EP1865952A4 (en) COMPOSITIONS CONTAINING HISTAMINES FOR THE TREATMENT OF ALLERGIES
BRPI0718420A2 (pt) Método de restabelecimento do efeito da incretina
FI20065374L (sv) Taktäckning och förfarande för framställning av detsamma
SE0601384L (sv) Anordning och förfarande för ytbehandling av föremål
ZA200900543B (en) Compositions and methods for the treatment of mucormycosis and other fungal diseases

Legal Events

Date Code Title Description
NAV Patent application has lapsed